COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03128879
Brief Title: Venetoclax and Ibrutinib in Treating Participants With High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

First Submitted : April 21, 2017
First Submitted that Met QC Criteria : April 21, 2017
First Posted : April 25, 2017

Last Update Submitted that Met QC Criteria : August 7, 2019
Last Update Posted : August 9, 2019